Nicolaas Schaap

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi et al. · The Lancet Haematology · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process

Jan Spanholtz, Frank Preijers, Marleen Tordoir et al. · PLoS ONE · 2011 · 238 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR

Menskin, Van De Locht, Schattenberg et al. · British Journal of Haematology · 1998 · 234 citations

Life Sciences, Hematology, Molecular Biology +17

Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods

Marleen Luten, Bregt Roerdinkholder‐Stoelwinder, Nicolaas Schaap et al. · Transfusion · 2008 · 223 citations

Medicine, Hematology, Surgery +13

Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

Harry Dolstra, Mieke W.H. Roeven, Jan Spanholtz et al. · Clinical Cancer Research · 2017 · 211 citations

Medicine, Hematology, Immunology +17